Publicacions en què col·labora amb MARTA EUGENIA ALARCON RIQUELME (22)

2024

  1. Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus

    Clinical Immunology, Vol. 264

  2. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

    Kidney International Reports, Vol. 9, Núm. 6, pp. 1817-1835

  3. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 7, pp. 889-900

  4. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

  5. Response to the letter 'testing the effectiveness of MyPROSLE in classifying patients with lupus nephritis'

    Briefings in Bioinformatics

2023

  1. Corrigendum to ‘Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus’ [J. Autoimmun. 136 (April 2023) 103025] (Journal of Autoimmunity (2023) 136, (S0896841123000343), (10.1016/j.jaut.2023.103025))

    Journal of Autoimmunity

  2. Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 136

2022

  1. Scoring personalized molecular portraits identify Systemic Lupus Erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression

    Briefings in bioinformatics, Vol. 23, Núm. 5

  2. Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection

    Nature Communications, Vol. 13, Núm. 1

2021

  1. A comprehensive database for integrated analysis of omics data in autoimmune diseases

    BMC Bioinformatics, Vol. 22, Núm. 1

  2. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  3. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases

    Journal of Translational Autoimmunity, Vol. 4

  4. Epigenetics in systemic lupus erythematosus and the integration of molecular pathways

    Lahita’s Systemic Lupus Erythematosus (Elsevier), pp. 35-61

  5. Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology

    Arthritis & rheumatology (Hoboken, N.J.), Vol. 73, Núm. 7, pp. 1288-1300

  6. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation

    Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321

  7. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  8. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1218-1226

2019

  1. Epigenome-wide comparative study reveals key differences between mixed connective tissue disease and related systemic autoimmune diseases

    Frontiers in Immunology, Vol. 10, Núm. AUG

2018

  1. Moving towards a molecular taxonomy of autoimmune rheumatic diseases

    Nature Reviews Rheumatology, Vol. 14, Núm. 2, pp. 75-93